Please login to the form below
Cello Health BioConsulting appoints Jim Hall as president
Senior pharma marketer to preside over newly-formed consulting firm
Cello Health BioConsulting has appointed senior pharma marketer Jim Hall as president.
Hall joins with over 20 years of experience in the life sciences industry and, prior to joining Cello Health BioConsulting, was senior VP of Campbell Alliance's Corporate Development Practice and senior partner at Oliver Wyman in the health and life science practice.
Jon Bircher, global CEO of Cello Health consulting, said: “Jim brings an unparalleled knowledge and understanding of the US and global market, of great quality consulting and is the perfect person to lead the bioconsulting team, helping expand Cello Health's footprint in the United States and beyond.”
Julia Ralston, CEO of Cello Health US, added: “He will drive our expansion, not only working with our growing team of strong consultants as leading advisors to the bio-pharmaceutical and healthcare sector, but also contributing to our overarching Cello Health strategy.”
Hall will be based at the firm's Boston office and is the second recent hire for Cello Health BioConsulting.
Featured jobs
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- GSK hires Merck KGaA exec to lead US pharma business
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- Novartis chooses internal replacement for US pharma president role
- AZ’s Imfinzi combo bombs again in non-small cell lung cancer
- NICE’s fast-track catapults Skyrizi into market
- GSK files anaemia drug daprodustat in Japan, its first market
- A uniquely English genomic medicine service
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- AZ claims first-in-class win for Farxiga in heart failure
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
- The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
- Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....
Quick links
Infographics
